Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $29.95 USD
Change Today 0.00 / 0.00%
Volume 0.0
TRUMF On Other Exchanges
As of 8:10 PM 11/5/15 All times are local (Market data is delayed by at least 15 minutes).

terumo corp (TRUMF) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/5/15 - $29.95
52 Week Low
12/17/14 - $22.75
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TERUMO CORP (TRUMF)

Related News

No related news articles were found.

terumo corp (TRUMF) Related Businessweek News

No Related Businessweek News Found

terumo corp (TRUMF) Details

Terumo Corporation manufactures and sells medical products and equipment worldwide. The company operates through Cardiac & Vascular, General Hospital, and Blood Management segments. Its cardiac and vascular products primarily comprise interventional devices that include access devices, such as introducer sheaths, guidewires, and guiding catheters; therapeutic devices, which include balloon catheters and stents; intravascular imaging systems; and cardiopulmonary bypass systems comprising oxygenator with integrated arterial filters, heart-lung machines, and artificial thoracic vascular grafts. The company’s general hospital products principally include infusion systems, including infusion pumps, infusion solutions, IV catheter, and infusion line connectors; drug and devices comprising prefilled syringes and prefillable syringes; nutritional supplements; measuring devices systems with communication functions, such as blood glucose meters, blood pressure monitors, and thermometers; pain management medicines that include analgesic and antiemetic; and closed anticancer drug infusion systems. Its blood management products primarily comprise automated blood collection systems, blood bag systems with leukocyte reduction filters, automated blood component processing system, pathogen reduction technology systems, therapeutic apheresis systems, and cell expansion systems. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was founded in 1921 and is headquartered in Tokyo, Japan.

19,934 Employees
Last Reported Date: 06/25/15
Founded in 1921

terumo corp (TRUMF) Top Compensated Officers

Senior Executive Officer, Director, Chief Exe...
Total Annual Compensation: ¥108.0M
Compensation as of Fiscal Year 2015.

terumo corp (TRUMF) Key Developments

Terumo Corporation Reports Earnings Results for the First Half of 2016

Terumo Corporation reported earnings results for the first half of 2016. For the period, operating income grew 19% year-on-year, due to increased gross profit from expanded sales and good SG&A control. Ordinary income increased 5% year-on-year. This growth rate was less than that of operating income, but the difference was due to foreign exchange losses. Net profit increased 23% year-on-year due to JPY 4.4 billion resulting from sale of land in Hatagaya, Tokyo. First half result came out JPY 4.2 billion for sales and JPY 2.1 billion for operating income, ahead of revised forecast. Operating income for the first half increased JPY 6.1 billion from JPY 33 billion the previous year for a result of JPY 39.1 billion.

Terumo Corporation Revises Guidance for Interim Dividend, Payable on December 7, 2015; Provides Year End Dividend Guidance For the Year Ending March 31, 2016

Terumo Corporation announced that at its board meeting held on November 5, 2015, the board revised interim dividend guidance of JPY 19 per share compared to JPY 16 per share previously forecasted. The company considers the distribution of an appropriate amount of profit to shareholders to be one of the principal responsibilities of management and pays dividends in accordance with a policy of stably and steadily increasing dividends with a target payout ratio of 30% over the medium to long-term. Record date for the distribution is September 30, 2015. The dividend will be payable on December 7, 2015. The company provided year end dividend guidance for the year ending March 31, 2016 of JPY 19 per share.

Terumo Corporation Approves Partial Amendment to the Articles of Incorporation

Terumo Corporation at its annual general meeting of shareholders approved partial amendment to the articles of incorporation.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TRUMF:US $29.95 USD 0.00

TRUMF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CR Bard Inc $187.40 USD +1.16
Edwards Lifesciences Corp $163.67 USD +3.26
Olympus Corp ¥4,915 JPY +15.00
Smith & Nephew PLC 1,133 GBp +16.00
St Jude Medical Inc $62.97 USD +0.19
View Industry Companies

Industry Analysis


Industry Average

Valuation TRUMF Industry Range
Price/Earnings 35.8x
Price/Sales 2.9x
Price/Book 2.5x
Price/Cash Flow 33.7x
TEV/Sales 2.0x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TERUMO CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at